TCTR20240723005尚未招募不适用
Antibody persistence against diphtheria, tetanus, pertussis, hepatitis B, measles, mumps and rubella in 9-12-year-old Thai children following immunization with pentavalent and hexavalent vaccines, and the immunogenicity of Tdap administered at 11 years of age
Ratchadapiseksomphot Endowment Fund, Chulalongkorn University0 个研究点目标入组 250 人开始时间: 2024年7月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 9 Years 至 12 Years（—）
- 性别
- All
入选标准
- •Children aged 9-12 years
- •Previous immunization with either pentavalent or hexavalent vaccines
- •Informed consent obtained from parents/guardians
排除标准
- •1. Serious underlying medical condition e.g. genetic disorder such as Down syndrome, children in immunosuppressive state or receiving immunosuppressive agents, human immunodeficiency virus infection, chronic lung or heart disease, chronic liver or kidney disease, history of chronic or recurrent infections.
- •2. Primary or secondary humoral immune disorders
- •3. History of adverse reactions to vaccines
- •4. Participation in another clinical study
研究者
相似试验
招募中
4 期
Antibody persistence against diphtheria, tetanus, pertussis, hepatitis B, measles, mumps and rubella in 5-8-year-old Thai children following primary and first booster immunization with pentavalent vs. hexavalent vaccinesVaccine immunogenicitydiphtheria toxoid, tetanus toxoid, aellular pertussis , whole-cell pertussis, mealses, mumps, rubella, hepatitis B. childrenTCTR20231017001ational Reserach Council of Thailand (NRCT)200
进行中（未招募）
不适用
Immunogenicity and safety of a tetanus, diphtheria and mono component acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as a booster vaccination to adultsThe intended use of the vaccine in this study is to increase the immunological protection against pertussis in adults who completed primary vaccination with diphtheria, tetanus and pertussis vaccine typically during their childhood.MedDRA version: 12.0Level: LLTClassification code 10034738Term: PertussisEUCTR2009-013411-36-DKStatens Serum Institut
招募中
不适用
Immune response after diphtheria and tetanus toxoid booster in patients with adult onset immunodeficiency with anti-interferon gamma autoantibodyInterferon gamma autoantibodyinterferon gamma autoantibodyDiphtheria toxoidTetanus toxoidImmune responseTCTR20190422001Ratchadapiseksompoch funds36
进行中（未招募）
不适用
Safety and Immunogenicity of ADACEL™ (TdcP Vaccine) Compared with QUADRACEL™ (HCPDT-mIPV Vaccine) as Fifth Dose in Children 4-6 Years of AgeEUCTR2015-005589-43-Outside-EU/EEASanofi Pasteur Limited600
已完成
不适用
Evaluation of the immune system response to Diphtheria and Tetanus vaccination in HIV positive patientsHIV AIDS.Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesIRCT201211204076N8Resaerch Deputy tehran university of medical sciences300